|
Formulary
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
FDA has issued an alert to healthcare professionals noting that there ...
September 01, 2008
Vivitrol.(Safety labeling updates & new warnings)(Report)(Brief articl...
September 01, 2008
Primary androgen deprivation therapy does not prolong survival in most...
September 01, 2008
Comparative effectiveness research legislation likely to raise drug pr...
September 01, 2008
Insulin glulisine.(Selected literature)(Brief article)
September 01, 2008
Mitiglinide.(Selected literature)(Brief article)
September 01, 2008
Oral insulin spray.(Selected literature)(Brief article)
September 01, 2008
Rimonabant.(Selected literature)(Brief article)
September 01, 2008
Selected websites.(Drug Watch)(Website list)(Brief article)
September 01, 2008
Types 1 and 2 diabetes mellitus.(Drug Watch: A HEADS-UP ON PHARMACEUTI...
September 01, 2008
Zipsor.(Approvable designations)(Drug overview)(Brief article)
September 01, 2008
Actemra.(Recommended for approval)(Drug overview)(Brief article)
September 01, 2008
Sugammadex.(Nonapprovable designations)(Drug overview)(Brief article)
September 01, 2008
Fospropofol.(Nonapprovable designations)(Drug overview)(Brief article)
September 01, 2008
Iloperidone.(Nonapprovable designations)(Drug overview)(Brief article)
September 01, 2008
Lacosamide.(Nonapprovable designations)(Drug overview)(Brief article)
September 01, 2008
Vascular endothelial growth factor b.(Orphan drug designations)(Drug o...
September 01, 2008
First-time generic approvals.(FDA Drug Approvals)(Drug overview)(Brief...
September 01, 2008
Viread: Tenofovir.(New indication)(Drug overview)
September 01, 2008
Single-pill combinations of valsartan and hydrochlorothiazide (Diovan ...
September 01, 2008
Stavzor.(FDA actions in brief)(Drug overview)(Brief article)
September 01, 2008
Cleviprex.(FDA actions in brief)(Drug overview)(Brief article)
September 01, 2008
Eovist.(FDA actions in brief)(Drug overview)(Brief article)
September 01, 2008
FDA approved 2 drug-eluting (Promus Everolimus-Eluting, Boston Scienti...
September 01, 2008
Alogliptin: a dipeptidyl peptidase-IV inhibitor for the treatment of t...
September 01, 2008
Potentially inappropriate medication use in hospitalized older adults:...
September 01, 2008
Rofecoxib, valdecoxib associated with increased risk of stroke.(FROM T...
September 01, 2008
Topical alprostadil cream.(Nonapprovable designations)(Drug overview)(...
September 01, 2008
|